CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses

Infection and Immunity

Volumn 78, Issue 12, 2010, Pages 5295-5306

  Truscott, Steven M ^a   Abate, Getahun ^a,b   Price, Jeffrey D ^c,d   Kemper, Claudia ^c,e   Atkinson, John P ^c   Hoft, Daniel F ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St Mary's Health Center   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD3 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; FAS LIGAND; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; MEMBRANE COFACTOR PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; T LYMPHOCYTE RECEPTOR; VASCULOTROPIN;

ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; DOWN REGULATION; HUMAN; IMMUNITY; IMMUNOREGULATION; IN VITRO STUDY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD46; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYBRIDOMAS; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, REGULATORY;

EID: 78649924129     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00513-10     Document Type: Article

References (55)

1. Alford, S. K., G. D. Longmore, W. F. Stenson, and C. Kemper. 2008. CD46-induced immunomodulatory CD4+ T cells express the adhesion molecule and chemokine receptor pattern of intestinal T cells. J. Immunol. 181:2544-2555.
2. Astier, A., M. C. Trescol-Biemont, O. Azocar, B. Lamouille, and C. Rabourdin- Combe. 2000. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J. Immunol. 164:6091-6095. (Pubitemid 30408783)
3. Astier, A. L., G. Meiffren, S. Freeman, and D. A. Hafler. 2006. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 116:3252-3257.
4. Barchet, W., J. D. Price, M. Cella, M. Colonna, S. K. MacMillan, J. P. Cobb, P. A. Thompson, K. M. Murphy, J. P. Atkinson, and C. Kemper. 2006. Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation. Blood 107:1497-1504. (Pubitemid 43242387)
5. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3:253-257.
6. Cardone, J., F. G. Le, P. Vantourout, A. Roberts, A. Fuchs, I. Jackson, T. Suddason, G. Lord, J. P. Atkinson, A. Cope, A. Hayday, and C. Kemper. 2010. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 11:862-871.
7. Cattaneo, R. 2004. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as a pathogens' magnet. J. Virol. 78:4385-4388. (Pubitemid 38501058)
8. Charles, M., and J. W. Pape. 2006. Tuberculosis and HIV: implications in the developing world. Curr. HIV AIDS Rep. 3:139-144.
9. Cho, S., V. Mehra, S. Thoma-Uszynski, S. Stenger, N. Serbina, R. J. Mazzaccaro, J. L. Flynn, P. F. Barnes, S. Southwood, E. Celis, B. R. Bloom, R. L. Modlin, and A. Sette. 2000. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 97:12210-12215.
10. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 271:698-702.
11. de Valliére, S., G. Abate, A. Blazevic, R. M. Heuertz, and D. F. Hoft. 2005. Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies. Infect. Immun. 73:6711-6720.
12. Espinal, M. A., S. J. Kim, P. G. Suarez, K. M. Kam, A. G. Khomenko, G. B. Migliori, J. Baez, A. Kochi, C. Dye, and M. C. Raviglione. 2000. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 283:2537-2545.
13. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U. S. A. 89:12013-12017.
14. Fuchs, A., J. P. Atkinson, V. Fremeaux-Bacchi, and C. Kemper. 2009. CD46-induced human Treg enhance B-cell responses. Eur. J. Immunol. 39:3097-3109.
15. Gonzalez-Juarrero, M., O. C. Turner, J. Turner, P. Marietta, J. V. Brooks, and I. M. Orme. 2001. Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 69:1722-1728.
16. Grossman, W. J., J. W. Verbsky, W. Barchet, M. Colonna, J. P. Atkinson, and T. J. Ley. 2004. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21:589-601.
17. Grossman, W. J., J. W. Verbsky, B. L. Tollefsen, C. Kemper, J. P. Atkinson, and T. J. Ley. 2004. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104:2840-2848.
18. Hoebe, K., E. Janssen, and B. Beutler. 2004. The interface between innate and adaptive immunity. Nat. Immunol. 5:971-974.
19. Hoft, D. F. 2008. Tuberculosis vaccine development: goals, immunological design, and evaluation. Lancet 372:164-175.
20. Hoft, D. F., A. Blazevic, G. Abate, W. A. Hanekom, G. Kaplan, J. H. Soler, F. Weichold, L. Geiter, J. C. Sadoff, and M. A. Horwitz. 2008. A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J. Infect. Dis. 198:1491-1501.
21. Hoft, D. F., R. Brown, and S. Roodman. 1998. Bacille Calmette- Guérin vaccination enhances human γδ T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J. Immunol. 161:1045-1054.
22. Ito, T., S. Hanabuchi, Y. H. Wang, W. R. Park, K. Arima, L. Bover, F. X. Qin, M. Gilliet, and Y. J. Liu. 2008. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28:870-880.
23. Jeevan, A., C. T. McFarland, T. Yoshimura, T. Skwor, H. Cho, T. Lasco, and D. N. McMurray. 2006. Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation. Infect. Immun. 74:213-224.
24. Kaufmann, S. H. 2001. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1:20-30.
25. Kemper, C., and J. P. Atkinson. 2007. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 7:9-18.
26. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421:388-392.
27. Liszewski, M. K., C. Kemper, J. D. Price, and J. P. Atkinson. 2005. Emerging roles and new functions of CD46. Springer Semin. Immunopathol. 27:345-358.
28. Liszewski, M. K., M. Leung, W. Cui, V. B. Subramanian, J. Parkinson, P. N. Barlow, M. Manchester, and J. P. Atkinson. 2000. Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J. Biol. Chem. 275:37692-37701.
29. Liszewski, M. K., T. W. Post, and J. P. Atkinson. 1991. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9:431-455.
30. Ma, A., Z. Xiong, Y. Hu, S. Qi, L. Song, H. Dun, L. Zhang, D. Lou, P. Yang, Z. Zhao, X. Wang, D. Zhang, P. Daloze, and H. Chen. 2009. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in cynomolgus monkeys. Int. Immunopharmacol. 9:599-608.
31. Marie, J. C., A. L. Astier, P. Rivailler, C. Rabourdin-Combe, T. F. Wild, and B. Horvat. 2002. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat. Immunol. 3:659-666.
32. Martinez-Forero, I., R. Garcia-Munoz, S. Martinez-Pasamar, S. Inoges, A. Lopez-Diaz de Cerio, R. Palacios, J. Sepulcre, B. Moreno, Z. Gonzalez, B. Fernandez-Diez, I. Melero, M. Bendandi, and P. Villoslada. 2008. IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. Eur. J. Immunol. 38:576-586.
33. McGuirk, P., C. McCann, and K. H. Mills. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:221-231.
34. Moore, K. W., M. R. de Waal, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
35. O'Garra, A., and P. Vieira. 2004. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10:801-805.
36. Olin, M. R., C. K. Hwa, J. Lee, and T. W. Molitor. 2005. γδ T lymphocyte cytotoxic activity against Mycobacterium bovis analyzed by flow cytometry. J. Immunol. Methods 297:1-11.
37. Pandiyan, P., L. Zheng, S. Ishihara, J. Reed, and M. J. Lenardo. 2007. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8:1353-1362.
38. Price, J. D., J. Schaumburg, C. Sandin, J. P. Atkinson, G. Lindahl, and C. Kemper. 2005. Induction of a regulatory phenotype in human CD4+ T cells by streptococcal M protein. J. Immunol. 175:677-684. (Pubitemid 41094947)
39. Riley-Vargas, R. C., D. B. Gill, C. Kemper, M. K. Liszewski, and J. P. Atkinson. 2004. CD46: expanding beyond complement regulation. Trends Immunol. 25:496-503.
40. Riley-Vargas, R. C., S. Lanzendorf, and J. P. Atkinson. 2005. Targeted and restricted complement activation on acrosome-reacted spermatozoa. J. Clin. Invest. 115:1241-1249.
41. Russell, S. 2004. CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function. Tissue Antigens 64:111-118. (Pubitemid 38969575)
42. Sanchez, A., M. J. Feito, and J. M. Rojo. 2004. CD46-mediated costimulation induces a Th1-biased response and enhances early TCR/CD3 signaling in human CD4+ T lymphocytes. Eur. J. Immunol. 34:2439-2448.
43. Sharma, S. K., and A. Mohan. 2006. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 130:261-272.
44. 2 T cells mediate protective tuberculosis immunity. J. Immunol. 181:4471-4484.
45. Strainic, M. G., J. Liu, D. Huang, F. An, P. N. Lalli, N. Muqim, V. S. Shapiro, G. R. Dubyak, P. S. Heeger, and M. E. Medof. 2008. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28:425-435.
46. Thurner, B., C. Roder, D. Dieckmann, M. Heuer, M. Kruse, A. Glaser, P. Keikavoussi, E. Kampgen, A. Bender, and G. Schuler. 1999. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J. Immunol. Methods 223:1-15. (Pubitemid 29096234)
47. Tsujimura, A., K. Shida, M. Kitamura, M. Nomura, J. Takeda, H. Tanaka, M. Matsumoto, K. Matsumiya, A. Okuyama, Y. Nishimune, M. Okabe, and T. Seya. 1998. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem. J. 330:163-168.
48. Tully, G., C. Kortsik, H. Hohn, I. Zehbe, W. E. Hitzler, C. Neukirch, K. Freitag, K. Kayser, and M. J. Maeurer. 2005. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection. J. Immunol. 174:2174-2184.
49. van Helden, P. D., P. R. Donald, T. C. Victor, H. S. Schaaf, E. G. Hoal, G. Walzl, and R. M. Warren. 2006. Antimicrobial resistance in tuberculosis: an international perspective. Expert Rev. Anti Infect. Ther. 4:759-766.
50. van Stipdonk, M. J., E. E. Lemmens, and S. P. Schoenberger. 2001. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2:423-429.
51. Wang, G., M. K. Liszewski, A. C. Chan, and J. P. Atkinson. 2000. Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation. J. Immunol. 164:1839-1846.
52. White, J., P. Lukacik, D. Esser, M. Steward, N. Giddings, J. R. Bright, S. J. Fritchley, B. P. Morgan, S. M. Lea, G. P. Smith, and R. A. Smith. 2004. Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli. Protein Sci. 13:2406-2415.
53. Worku, S., and D. F. Hoft. 2003. Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Infect. Immun. 71:1763-1773.
54. Worku, S., and D. F. Hoft. 2000. In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guerin. Clin. Infect. Dis. 30(Suppl. 3):S257-S261.
55. Zaffran, Y., O. Destaing, A. Roux, S. Ory, T. Nheu, P. Jurdic, C. Rabourdin-Combe, and A. L. Astier. 2001. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J. Immunol. 167:6780-6785.